Your browser doesn't support javascript.
loading
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Klein, Eric A; Cooperberg, Matthew R; Magi-Galluzzi, Cristina; Simko, Jeffry P; Falzarano, Sara M; Maddala, Tara; Chan, June M; Li, Jianbo; Cowan, Janet E; Tsiatis, Athanasios C; Cherbavaz, Diana B; Pelham, Robert J; Tenggara-Hunter, Imelda; Baehner, Frederick L; Knezevic, Dejan; Febbo, Phillip G; Shak, Steven; Kattan, Michael W; Lee, Mark; Carroll, Peter R.
Affiliation
  • Klein EA; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address: kleine@ccf.org.
  • Cooperberg MR; Department of Urology, University of California, San Francisco and UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Magi-Galluzzi C; Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Simko JP; Department of Urology, University of California, San Francisco and UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.
  • Falzarano SM; Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Maddala T; Genomic Health, Inc., Redwood City, CA, USA.
  • Chan JM; Department of Urology, University of California, San Francisco and UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Li J; Genomic Health, Inc., Redwood City, CA, USA.
  • Cowan JE; Department of Urology, University of California, San Francisco and UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
  • Tsiatis AC; Genomic Health, Inc., Redwood City, CA, USA.
  • Cherbavaz DB; Genomic Health, Inc., Redwood City, CA, USA.
  • Pelham RJ; Genomic Health, Inc., Redwood City, CA, USA.
  • Tenggara-Hunter I; Department of Urology, University of California, San Francisco and UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
  • Baehner FL; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA; Genomic Health, Inc., Redwood City, CA, USA.
  • Knezevic D; Genomic Health, Inc., Redwood City, CA, USA.
  • Febbo PG; Genomic Health, Inc., Redwood City, CA, USA.
  • Shak S; Genomic Health, Inc., Redwood City, CA, USA.
  • Kattan MW; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
  • Lee M; Genomic Health, Inc., Redwood City, CA, USA.
  • Carroll PR; Department of Urology, University of California, San Francisco and UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. Electronic address: pcarroll@urology.ucsf.edu.
Eur Urol ; 66(3): 550-60, 2014 Sep.
Article in En | MEDLINE | ID: mdl-24836057
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Gene Expression / Transcriptome / Neoplasm Recurrence, Local Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Humans / Male / Middle aged Language: En Journal: Eur Urol Year: 2014 Document type: Article Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Gene Expression / Transcriptome / Neoplasm Recurrence, Local Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Humans / Male / Middle aged Language: En Journal: Eur Urol Year: 2014 Document type: Article Country of publication: Switzerland